Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans

This study was intended to determine the incidence rate of warfarin-related adverse events (e.g., bleeding) in Puerto Ricans and whether a genetic association between warfarin pharmacogenes and any of these adverse events was observed over the initiation period (i.e., the first 90 days of therapy)....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Puerto Rico health sciences journal 2014-09, Vol.33 (3), p.97-104
Hauptverfasser:	Valentín, Isa I, Rivera, Giselle, Nieves-Plaza, Mariely, Cruz, Iadelisse, Renta, Jessica Y, Cadilla, Carmen L, Feliu, Juan F, Seip, Richard L, Ruaño, Gualberto, Duconge, Jorge
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anticoagulants - administration & dosage Anticoagulants - adverse effects Cohort Studies Genotype Hemorrhage - chemically induced Hemorrhage - genetics Humans Middle Aged Puerto Rico Retrospective Studies Warfarin - administration & dosage Warfarin - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!